2008-05-12

May Letter to Shareholders from Patriot Scientific President and CEO Rick Goerner

......The board has also agreed that we should evaluate listing on a more broadly traded exchange, such as NASDAQ or NYSE/AMEX once we have developed a strategy, and acquired sufficient revenue-producing assets, to attract broader, institutional investors in PTSC stock. Our current stock price would not allow the company to consider re-listing on another exchange. The normal means to adjust the stock price to meet listing requirements would be a reverse split of the stock. The board is not anxious to move toward a reverse split until it believes that:

1. The company has a reliable, long term opportunity for growth of (less volatile) revenues, profits and shareholder value and,

2. A reverse split will not risk a reduction of the market capitalization of the company.

Again, no definitive timeline has been outlined for considering these actions, but I believe that the shareholders understand the company’s objectives, and perspectives, with respect to these possible actions.